Nine-month study data boost Abbott's dissolving stent
This article was originally published in Clinica
Executive Summary
The bioabsorbable stent developed by Abbott has met with further clinical success, bringing it a step closer to becoming the first device of its kind to reach the market.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.